Nothing Special   »   [go: up one dir, main page]

SE9003296L - Foerfarande foer att formulera laekemedel - Google Patents

Foerfarande foer att formulera laekemedel

Info

Publication number
SE9003296L
SE9003296L SE9003296A SE9003296A SE9003296L SE 9003296 L SE9003296 L SE 9003296L SE 9003296 A SE9003296 A SE 9003296A SE 9003296 A SE9003296 A SE 9003296A SE 9003296 L SE9003296 L SE 9003296L
Authority
SE
Sweden
Prior art keywords
pellets
pct
dosage
cohesive
date apr
Prior art date
Application number
SE9003296A
Other languages
Unknown language ( )
English (en)
Other versions
SE9003296D0 (sv
Inventor
A Kristensen
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9003296A priority Critical patent/SE9003296L/sv
Publication of SE9003296D0 publication Critical patent/SE9003296D0/sv
Priority to DE69115711T priority patent/DE69115711T2/de
Priority to JP51707291A priority patent/JP3459011B2/ja
Priority to AT91918066T priority patent/ATE131727T1/de
Priority to CA002094030A priority patent/CA2094030C/en
Priority to US08/039,175 priority patent/US5476667A/en
Priority to EP91918066A priority patent/EP0553169B1/en
Priority to ES91918066T priority patent/ES2081498T3/es
Priority to PCT/SE1991/000690 priority patent/WO1992006679A1/en
Priority to AU87459/91A priority patent/AU650683B2/en
Priority to DK91918066.1T priority patent/DK0553169T3/da
Priority to PT99245A priority patent/PT99245B/pt
Priority to IE362791A priority patent/IE74194B1/en
Publication of SE9003296L publication Critical patent/SE9003296L/sv
Priority to GR960400760T priority patent/GR3019360T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9003296A 1990-10-16 1990-10-16 Foerfarande foer att formulera laekemedel SE9003296L (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9003296A SE9003296L (sv) 1990-10-16 1990-10-16 Foerfarande foer att formulera laekemedel
DK91918066.1T DK0553169T3 (da) 1990-10-16 1991-10-15 Fremgangsmåde til lægemiddelformulering samt farmaceutisk middel
EP91918066A EP0553169B1 (en) 1990-10-16 1991-10-15 A method for drug formulation and a pharmaceutical composition
PCT/SE1991/000690 WO1992006679A1 (en) 1990-10-16 1991-10-15 A method for drug formulation and a pharmaceutical composition
AT91918066T ATE131727T1 (de) 1990-10-16 1991-10-15 Verfahren zur arzneiformulierung sowie arzneimittel
CA002094030A CA2094030C (en) 1990-10-16 1991-10-15 A method for drug formulation and a pharmaceutical composition
US08/039,175 US5476667A (en) 1990-10-16 1991-10-15 Method for drug formulation and a pharmaceutical composition
DE69115711T DE69115711T2 (de) 1990-10-16 1991-10-15 Verfahren zur arzneiformulierung sowie arzneimittel
ES91918066T ES2081498T3 (es) 1990-10-16 1991-10-15 Un metodo para la formulacion de farmacos y una composicion farmaceutica.
JP51707291A JP3459011B2 (ja) 1990-10-16 1991-10-15 薬物配合方法及び医薬組成物
AU87459/91A AU650683B2 (en) 1990-10-16 1991-10-15 Melt granulating method for drug formulation
IE362791A IE74194B1 (en) 1990-10-16 1991-10-16 A method for drug formulation and a pharmaceutical composition
PT99245A PT99245B (pt) 1990-10-16 1991-10-16 Processo para a preparaccao de uma substancia sob a forma granulada contendo nomeadamente um sal de acido azobissalicilico e de uma composicao farmaceutica que a contem
GR960400760T GR3019360T3 (en) 1990-10-16 1996-03-19 A method for drug formulation and a pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003296A SE9003296L (sv) 1990-10-16 1990-10-16 Foerfarande foer att formulera laekemedel

Publications (2)

Publication Number Publication Date
SE9003296D0 SE9003296D0 (sv) 1990-10-16
SE9003296L true SE9003296L (sv) 1992-04-17

Family

ID=20380654

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003296A SE9003296L (sv) 1990-10-16 1990-10-16 Foerfarande foer att formulera laekemedel

Country Status (14)

Country Link
US (1) US5476667A (sv)
EP (1) EP0553169B1 (sv)
JP (1) JP3459011B2 (sv)
AT (1) ATE131727T1 (sv)
AU (1) AU650683B2 (sv)
CA (1) CA2094030C (sv)
DE (1) DE69115711T2 (sv)
DK (1) DK0553169T3 (sv)
ES (1) ES2081498T3 (sv)
GR (1) GR3019360T3 (sv)
IE (1) IE74194B1 (sv)
PT (1) PT99245B (sv)
SE (1) SE9003296L (sv)
WO (1) WO1992006679A1 (sv)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
GB2284760B (en) * 1993-11-23 1998-06-24 Euro Celtique Sa A method of preparing pharmaceutical compositions by melt pelletisation
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
IL109460A (en) * 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
IL109944A (en) † 1993-07-01 1998-12-06 Euro Celtique Sa Continuous release dosage form containing morphine and a method of preparing such sustained release unit dosage forms
WO1995009044A1 (en) * 1993-09-29 1995-04-06 E.I. Du Pont De Nemours And Company Melt granulation with dielectric heating
EP0654263B1 (en) * 1993-11-23 2002-01-23 Euro-Celtique S.A. Method for preparing a sustained release composition
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
EP0672416A1 (en) * 1994-03-14 1995-09-20 Euro-Celtique S.A. Pharmaceutical composition comprising diamorphine
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
GB9422154D0 (en) † 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
GB9519363D0 (en) 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
SE9700934D0 (sv) 1997-03-14 1997-03-14 Astra Ab New formulation
US5981499A (en) * 1998-02-20 1999-11-09 Atlantic Biomed Corporation Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
PT1146862E (pt) 1999-01-29 2003-09-30 Disphar Int Bv Composicoes farmaceuticas
US6248718B1 (en) 1999-08-18 2001-06-19 Atlantic Biomed Corporation Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
CN1407884B (zh) 1999-10-29 2012-06-20 欧罗赛铁克股份有限公司 控释氢可酮制剂
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
MXPA03003895A (es) 2000-10-30 2003-07-28 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada.
FR2816507B1 (fr) * 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10300325A1 (de) 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
US20040265378A1 (en) * 2003-06-25 2004-12-30 Yingxu Peng Method and compositions for producing granules containing high concentrations of biologically active substances
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
CA2555304C (en) 2004-02-06 2016-06-28 Nicolas Peter Shortis Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
US8921344B2 (en) 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US7452872B2 (en) 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
EP1972335A1 (en) * 2007-03-23 2008-09-24 Krka Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
FR2918277B1 (fr) * 2007-07-06 2012-10-05 Coretecholding Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
BRPI0819231B8 (pt) 2007-10-31 2021-05-25 Mcneil Ppc Inc processo para preparo de forma farmacêutica de desintegração rápida por moldagem a quente na presença de sal inorgânico hidratado
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US20110070301A1 (en) * 2009-09-24 2011-03-24 Luber Joseph R Orally transformable tablets
DE102012007671A1 (de) 2012-04-16 2013-10-17 Acino Pharma Ag Pellets mit hohem Wirkstoffgehalt
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
FR3014317B1 (fr) 2013-12-11 2016-04-22 Patrice Binay Nouveau procede de fabrication de formulations pharmaceutiques transmuqueuses et formations ainsi obtenues
BR112016015944A8 (pt) 2014-01-10 2020-06-09 Johnson & Johnson Consumer Inc processo para produzir comprimido, que usa radiofrequência e partículas revestidas dissipadoras de energia
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
US4129666A (en) * 1977-04-29 1978-12-12 Walter Wizerkaniuk Method of providing pellets with a water insoluble coating using a melt
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
DE3721721C1 (de) * 1987-07-01 1988-06-09 Hoechst Ag Verfahren zur Umhuellung von Granulaten

Also Published As

Publication number Publication date
AU8745991A (en) 1992-05-20
PT99245A (pt) 1992-09-30
ES2081498T3 (es) 1996-03-16
ATE131727T1 (de) 1996-01-15
DE69115711T2 (de) 1996-05-30
IE913627A1 (en) 1992-04-22
AU650683B2 (en) 1994-06-30
DK0553169T3 (da) 1996-05-13
IE74194B1 (en) 1997-07-16
WO1992006679A1 (en) 1992-04-30
EP0553169A1 (en) 1993-08-04
US5476667A (en) 1995-12-19
GR3019360T3 (en) 1996-06-30
PT99245B (pt) 1999-04-30
EP0553169B1 (en) 1995-12-20
CA2094030A1 (en) 1992-04-17
CA2094030C (en) 2003-06-17
SE9003296D0 (sv) 1990-10-16
JP3459011B2 (ja) 2003-10-20
JPH06502151A (ja) 1994-03-10
DE69115711D1 (de) 1996-02-01

Similar Documents

Publication Publication Date Title
SE9003296D0 (sv) Foerfarande foer att formulera laekemedel
FI870588A (sv) Förfarande för framställning av en fast doseringsform med långsam utlösning
HUT70938A (en) Retarde pharmaceutical compositions containing morphine and process for producing them
GR3024604T3 (en) Process for the preparation of sustained release pellets.
ES8501978A1 (es) Un procedimiento para preparar un agente anti-inflamatorio
ZA921659B (en) Low dose dry pharmaceutical preparations
DE3877764D1 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
ZA200005915B (en) Pharmaceutical compositions capable of being gelled.
ES2001993A6 (es) Un procedimiento para preparar un agente farmaceutico de liberacion lenta.
AU591258B2 (en) Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
MD872G2 (ro) Compoziţie farmaceutică efervescentă şi preparat pe baza ei, procedeu de fabricare a preparatului
ES8801121A1 (es) Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.
JPS6463522A (en) Pharmaceutical composition for treating and preventing gallstone and gall deficient indigestion
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
JPS57109721A (en) Carcinostatic agent
NZ512091A (en) Milling process for the production of finely milled crystalline material used for medicinal purpose
JPS5344617A (en) Drug composition
JPS5423254A (en) Equipment for treating pulverulent and granular bodies

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9003296-2

Format of ref document f/p: F